Nicole A. Mortier
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Blood groups and transfusion, Epigenetics and DNA Methylation, Bone and Joint Diseases
Most-Cited Works
- → Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial(2015)501 cited
- → Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease(2003)318 cited
- → Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia(2007)218 cited
- → Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy(2004)173 cited
- → Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia(2011)166 cited
- → Genetic predictors for stroke in children with sickle cell anemia(2011)146 cited
- → Glomerular hyperfiltration and albuminuria in children with sickle cell anemia(2011)127 cited
- → Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia(2012)111 cited
- → A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia(2008)98 cited
- → Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload(2011)76 cited